Table 3.

Factor V activity of activated platelets

AgonistFactor V Activity (mU/mL)
None  3.4 ± 0.2 
Convulxin (500 ng/mL)  25.6 ± 3.7  
Thrombin (5 nmol/L) 91.9 ± 12.9  
TRAP (100 μmol/L)  17.3 ± 1.6 
A23187 (2 μmol/L)  12.9 ± 1.5  
VCP (2 nmol/L) 8.3 ± 1.7  
Thrombin + convulxin  156.3 ± 18.9 
Thrombin + A23187  107.7 ± 24.0  
Convulxin + A23187 16.9 ± 1.1  
TRAP + VCP  48.3 ± 10.4 
A23187 + VCP  55.6 ± 8.5  
Convulxin + VCP 67.7 ± 11.6 
AgonistFactor V Activity (mU/mL)
None  3.4 ± 0.2 
Convulxin (500 ng/mL)  25.6 ± 3.7  
Thrombin (5 nmol/L) 91.9 ± 12.9  
TRAP (100 μmol/L)  17.3 ± 1.6 
A23187 (2 μmol/L)  12.9 ± 1.5  
VCP (2 nmol/L) 8.3 ± 1.7  
Thrombin + convulxin  156.3 ± 18.9 
Thrombin + A23187  107.7 ± 24.0  
Convulxin + A23187 16.9 ± 1.1  
TRAP + VCP  48.3 ± 10.4 
A23187 + VCP  55.6 ± 8.5  
Convulxin + VCP 67.7 ± 11.6 

Platelets activated with various agonists were added to FV-deficient plasma and 1-stage clotting times were measured as described in “Materials and methods.” Clotting times were converted to FV activity (mU/mL) by comparison with a normal plasma. TRAP, thrombin receptor agonist peptide; VCP, Factor V coagulant protein. Values are expressed as mean ± SE; n = 3-8.

or Create an Account

Close Modal
Close Modal